Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (171-180 of 386) with videos related to

Pageof 39
Sort By:
British Journal of Haematology|October 6, 2025
Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma linesXiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Molecular Pharmacology|August 28, 2012
Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathwayAlae Yaseen, Shuang Chen, Stefanie Hock, et al.
BMC Cancer|November 18, 2018
Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanismsTri Nguyen, Rebecca Parker, Yu Zhang, et al.
Cancer Research|April 19, 2003
The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent processChunrong Yu, Mohamed Rahmani, Yun Dai, et al.
Molecular Cancer Therapeutics|January 21, 2003
Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridolLeanne Cartee, Sonia C Maggio, Rebecca Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cellsYun Dai, Shuang Chen, Lora B Kramer, et al.
Molecular Cancer Therapeutics|December 7, 2002
The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cellsRoberto R Rosato, Jorge A Almenara, Leanne Cartee, et al.
Blood|March 27, 2012
Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent processMohamed Rahmani, Mandy Mayo Aust, Elisa Attkisson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells <i>In Vitro</i> and <i>In Vivo</i>Yu Zhang, Liang Zhou, Dipankar Bandyopadhyay, et al.
Blood|June 2, 2007
MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanismXin-Yan Pei, Yun Dai, Sarah Tenorio, et al.
Pageof 39

Showing results (171-180 of 386) with videos related to

Sort By:
Pageof 39
British Journal of Haematology|October 6, 2025
Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma linesXiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Molecular Pharmacology|August 28, 2012
Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathwayAlae Yaseen, Shuang Chen, Stefanie Hock, et al.
BMC Cancer|November 18, 2018
Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanismsTri Nguyen, Rebecca Parker, Yu Zhang, et al.
Cancer Research|April 19, 2003
The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent processChunrong Yu, Mohamed Rahmani, Yun Dai, et al.
Molecular Cancer Therapeutics|January 21, 2003
Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridolLeanne Cartee, Sonia C Maggio, Rebecca Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cellsYun Dai, Shuang Chen, Lora B Kramer, et al.
Molecular Cancer Therapeutics|December 7, 2002
The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cellsRoberto R Rosato, Jorge A Almenara, Leanne Cartee, et al.
Blood|March 27, 2012
Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent processMohamed Rahmani, Mandy Mayo Aust, Elisa Attkisson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells <i>In Vitro</i> and <i>In Vivo</i>Yu Zhang, Liang Zhou, Dipankar Bandyopadhyay, et al.
Blood|June 2, 2007
MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanismXin-Yan Pei, Yun Dai, Sarah Tenorio, et al.
Pageof 39